Hyam I. Levitsky

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.

K Y Lin, Frank Guarnieri, Kevin F. Staveley-O’Carroll et al. · PubMed · 1996 · 1K citations

Medicine, Immunology, Oncology +17

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

Eric R. Fearon, Drew M. Pardoll, Toshiuki Itaya et al. · Cell · 1990 · 922 citations

Life Sciences, Immunology, Oncology +17

Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4

Paul T. Golumbek, Audrey J. Lazenby, Hyam I. Levitsky et al. · Science · 1991 · 731 citations

Medicine, Immunology, Oncology +17

Depleting tumor-specific Tregs at a single site eradicates disseminated tumors

Aurélien Marabelle, Holbrook E. Kohrt, Idit Sagiv-Barfi et al. · Journal of Clinical Investigation · 2013 · 405 citations · Full text

Medicine, Immunology, Oncology +17

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

Leo Luznik, Javier Bolaños‐Meade, Marianna Zahurak et al. · Blood · 2010 · 404 citations · Full text

Life Sciences, Immunology, Pharmacology +14